INVOLVEMENT OF CYTOPLASMIC FACTORS REGULATING THE MEMBRANE ORIENTATION OF P-GLYCOPROTEIN SEQUENCES

被引:43
|
作者
ZHANG, JT [1 ]
LING, V [1 ]
机构
[1] UNIV TORONTO,ONTARIO CANC INST,DEPT MED BIOPHYS,DIV MOLEC & STRUCT BIOL,TORONTO,ON M4X 1K9,CANADA
关键词
D O I
10.1021/bi00028a027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chinese hamster pgp1 P-glycoprotein (Pgp) is a membrane transport protein that causes multidrug resistance (MDR) by actively extruding a wide variety of cytotoxic agents out of cells. It may also function as a peptide transporter and as a chloride channel. previously, we have shown that hamster pgp1 Pgp is expressed in more than one topological form and that the generation of these structures is modulated by charged amino acids flanking the predicted transmembrane (TM) segments 3 and 4. Different topological structures of Pgp may be involved in different functions. In this study, we examined the role of cytoplasmic components in cell-free translation systems in modulating the topologies of Pgp. By using rabbit reticulocyte lysate (RRL) and wheat germ extract (WGE) expression systems, we showed that WGE contains a soluble, heat-labile, high molecular weight fraction that regulates the membrane topology of a mammalian Pgp molecules. These results and our previous findings indicate that the membrane topology of a mammalian polytopic membrane protein may be regulated both by the amino acid sequence of the protein and by soluble cytoplasmic component(s). We speculate that Pgp expressed in various cell types may have different topological structures modulated by specific cytoplasmic factors.
引用
收藏
页码:9159 / 9165
页数:7
相关论文
共 50 条
  • [41] Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers
    Abbaszadegan, MR
    Cress, AE
    Futscher, BW
    Bellamy, WT
    Dalton, WS
    CANCER RESEARCH, 1996, 56 (23) : 5435 - 5442
  • [42] Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome
    Begley, GS
    Horvath, AR
    Taylor, JC
    Higgins, CF
    MOLECULAR IMMUNOLOGY, 2005, 42 (01) : 137 - 141
  • [43] Reconstituting human P-glycoprotein (MDR1) into membrane nanodiscs
    Farokhnia, Roxana
    Olivera, Maisa C.
    Okwuone, Dakota D. D.
    Jensen, Madeline K.
    Edgar, Jennifer M.
    Wise, John G.
    Vogel, Pia D.
    FASEB JOURNAL, 2019, 33
  • [44] P-glycoprotein kinetics measured in plasma membrane vesicles and living cells
    Aeaenismaa, Paeivi
    Seelig, Anna
    BIOCHEMISTRY, 2007, 46 (11) : 3394 - 3404
  • [45] INDIRECT MECHANISM OF DRUG TRANSPORT BY P-GLYCOPROTEIN - DRUG TRANSPORT MEDIATED BY P-GLYCOPROTEIN MAY BE SECONDARY TO ELECTROCHEMICAL PERTURBATIONS OF THE PLASMA-MEMBRANE
    ROEPE, PD
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (12) : 445 - 446
  • [46] MEMBRANE-TRANSPORT OF AMPHIPHILIC COMPOUNDS BY P-GLYCOPROTEIN, THE MULTIDRUG TRANSPORTER
    BUSCHE, R
    TUMMLER, B
    GAUCI, D
    RIORDAN, JR
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1989, 370 (07): : 617 - 617
  • [47] MEMBRANE TOPOLOGY OF A CYSTEINE-LESS MUTANT OF HUMAN P-GLYCOPROTEIN
    LOO, TW
    CLARKE, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) : 843 - 848
  • [48] Functional expression of P-glycoprotein in the hepatic canalicular membrane of developing rats
    Kamath, AV
    Morris, ME
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (03) : 300 - 305
  • [49] Induction of P-glycoprotein expression on the plasma membrane of human melanoma cells
    Molinari, A
    Toccacieli, L
    Calcabrini, A
    Diociaiuti, M
    Cianfriglia, M
    Arancia, G
    ANTICANCER RESEARCH, 2000, 20 (04) : 2691 - 2696
  • [50] Active participation of membrane lipids in inhibition of multidrug transporter P-glycoprotein
    Kapoor, Karan
    Pant, Shashank
    Tajkhorshid, Emad
    CHEMICAL SCIENCE, 2021, 12 (18) : 6293 - 6306